Nightingale Health Oyj

Equities

HEALTH

FI4000490875

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Helsinki Other stock markets 08:59:45 24/05/2024 pm IST			5-day change	1st Jan Change
1.695 ^EUR	-3.14%		+7.62%	+51.88%

16/04	Finland’s Nightingale Health Plots US Expansion	MT
16/04	Nightingale Health to Establish A Laboratory in the United States	CI

Nightingale Health plc Elects Leena Niemistö as Chair

November 17, 2022 at 09:45 pm IST

The Annual General Meeting of Nightingale Health Plc was held on 17 November 2022. In the organizational meeting held after the Annual General Meeting, the Board of Directors elected Leena Niemistö as chair from among its members.

Latest news about Nightingale Health Oyj

Finland’s Nightingale Health Plots US Expansion	16/04	MT
Nightingale Health to Establish A Laboratory in the United States	16/04	CI
Nightingale Health and the Englander Institute for Precision Medicine At Weill Cornell Medicine Sign A Letter of Intent in Which the Parties Agree to Collaborate on the Adoption of Nightingale Health's Proprietary Technology in Healthcare and Medical Research in the United States	16/04	CI
Nightingale Health Secures Blood Analysis Contract with Kaiser Foundation	12/04	MT
Nightingale Health Enters into Agreement to Analyze 50,000 Blood Samples with Kaiser Foundation Health Plan, Inc	12/04	CI
Nightingale Health Closes Purchase of Japan's Welltus	29/03	MT
Nightingale Health Oyj completed the acquisition of Welltus Inc from Mitsui & Co., Ltd. and Kirin Holdings Company, Limited.	29/03	CI
Nightingale Health plc Enters into an Agreement in Which It Will Analyze Blood Samples from Uganda's General Population Cohort	19/03	CI
Finland-based Nightingale Health to Buy Japan's Welltus	07/03	MT
Transcript : Nightingale Health Oyj, H1 2024 Earnings Call, Mar 07, 2024	07/03
Nightingale Health Oyj Reports Earnings Results for the Half Year Ended December 30, 2023	07/03	CI
Nightingale Health Oyj agreed to acquire Welltus Inc from Mitsui & Co., Ltd. and Kirin Holdings Company, Limited.	07/03	CI
Singaporean Regulator Approves Nightingale Health's Blood Analysis Technology	23/02	MT
Nightingale Health Oyj Receives Regulatory Approval for Healthcare Use from Health Sciences Authority in Singapore	23/02	CI
Nightingale Health Lands Five New Health Risk Detection Patents in Finland	31/01	MT
Nightingale Health plc Receives Five New Patents for Its Proprietary Health Risk Detection Capability	31/01	CI
Suomen Terveystalo Begins Using Nightingale Health's Blood Analysis Technology in Regular Health Checks in Occupational Health	02/01	CI
Terveystalo Integrates Nightingale Health's Blood Analysis Technology in Occupational Health	02/01	MT
Nightingale Health Completes the Analysis of All 500,000 UK Biobank Samples Creating the Largest Blood Biomarker Database for Chronic Disease Research and Prevention	13/12	CI
Nightingale Health plc Announces Maximilian Leroux Leaves as Chief Commercial Officer	27/11	CI
Nightingale Health and Innoquest Diagnostics Enter into Collaboration Agreement to Make Nightingale Health's Technology Accessible in the Southeast Asia Region	15/11	CI
Transcript : Nightingale Health Oyj, 2023 Earnings Call, Sep 28, 2023	28/23/28
Nightingale Health Oyj Reports Earnings Results for the Full Year Ended June 30, 2023	28/23/28	CI
Nightingale Health Secures Three New Patents in Finland	26/23/26	MT
Nightingale Health Receives Three New Patents Further Strengthening Its IP Portfolio	26/23/26	CI

Chart Nightingale Health Oyj

Duration

Period

More charts

Company Profile

Nightingale Health Oyj is a Finland-based health technology company that aims to promote preventative health and help people stay healthy. The blood analysis technology developed by Nightingale measures a broad group of biomarkers from a single blood sample, recognizing individual disease risks. The Company provides people with comprehensive insights on health, helps them make better decisions regarding their health and connects them with healthcare experts that offer preventative services for maintaining health. Nightingale Health Oy is the Parent Company in the Nightingale Group. The Group comprises the parent Companyâs subsidiaries: Nightingale Health United States Inc, Nightingale Health Asia Pte Ltd, Nightingale Health Japan KK as well as NG Health Sweden AB. The Company owns and independently oversees two laboratories in Finland, in Helsinki and Kuopio, and one laboratory in Tokyo, Japan.

Sector

Advanced Medical Equipment & Technology

More about the company

Income Statement Evolution

More financial data

Ratings for Nightingale Health Oyj

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

UNDERPERFORM

Number of Analysts

Last Close Price

1.695 EUR

Average target price

1.6 EUR

Spread / Average Target

-5.60%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Software & Technology Services

	1st Jan change	Capi.
NIGHTINGALE HEALTH OYJ	+51.88%	11Cr
VEEVA SYSTEMS INC.	+5.91%	3.3TCr
PRO MEDICUS LIMITED	+20.73%	801.14Cr
SECTRA AB	+34.25%	437.92Cr
EVOLENT HEALTH, INC.	-29.52%	266.96Cr
OMNICELL, INC.	-13.29%	149.85Cr
VERADIGM INC.	-28.02%	127.44Cr
LUNIT INC.	-30.53%	120.16Cr
SIMULATIONS PLUS, INC.	+11.35%	100Cr
B-SOFT CO.,LTD.	-38.17%	86Cr

Medical Software & Technology Services